[脂质体在结核病治疗中的潜在使用]
Yolanda Monserrath Jacobo-Delgado1, Gabriela Navarro-Tovar2, Bruno Rivas-Santiago1
1Instituto Mexicano del Seguro Social, Hospital General de Zona No. 1 "Dr. Emilio Varela Lujan", Unidad de Investigación Biomédica de Zacatecas. Zacatecas, Zacatecas, México.
Revista medica del Instituto Mexicano del Seguro Social
|September 28, 2023
概括
新的纳米技术方法,如脂质体,通过增强药物输送到肺部,为改善结核病治疗提供了有希望的途径. 这可以减少副作用,并对抗药物耐药性.
科学领域:
- 纳米医学是一种纳米医学.
- 药理学 药理学 是一个学科.
- 传染性疾病 传染性疾病
背景情况:
- 结核病 (TB) 仍然是全球传染病死亡的主要原因,呼吸道感染是最常见的.
- 目前的结核病治疗是漫长的,涉及多种抗生素,并引起不良影响导致治疗放弃和耐药性.
- 迫切需要新的治疗策略来缩短药物剂量和施用时间.
研究的目的:
- 审查纳米载体作为结核病治疗药物输送系统的应用.
- 分析当前的纳米载体配方及其改善结核病治疗的潜力.
- 探索纳米技术在开发新的抗结核药理疗法的未来前景.
主要方法:
- 关于纳米载体,特别是脂质体,用于结核病药物输送的科学文献的审查.
- 对专注于控制和指导药物释放系统的研究进行分析.
- 对旨在用于呼吸道的配方进行检查.
主要成果:
- 纳米载体,特别是脂质体,显示出向药物输送到呼吸道粘膜和肺部的潜力.
- 这些系统可以促进药物接触范围的扩大,并可能提高治疗疗效.
- 脂质体在结核病治疗中为呼吸道输送途径提供了优势.
结论:
- 纳米技术,通过像脂质体这样的系统,为开发先进的结核病治疗提供了一个有希望的途径.
- 这些基于纳米载体的方法可以减轻不良影响,并克服与传统结核病治疗相关的挑战.
- 对纳米载体配方的进一步研究对于推进结核病药物治疗至关重要.
相关概念视频
Pulmonary Tuberculosis V
194
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
194
Pulmonary Tuberculosis II
256
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
256
Pulmonary Tuberculosis I
257
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
257
Pulmonary Tuberculosis IV
157
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
157


